JPBSA:Japan Pharma Business Supportors Association
Straight to commercialize cutting-edge medical technology from startups in Japan and overseas
The Japan Association of Pharmaceutical Industry Supporters is an organization established by collaborating with experts who support Japan’s drug discovery capabilities. Professionals with extensive experience in various fields gather to gain a deep understanding of the issues faced by university researchers and entrepreneurs and to accurately solve them. Through specific and dedicated support, we aim to create new value for the pharmaceutical industry and build a sustainable ecosystem.
About us
Information from the Association (Notice)
- Joint Seminars:
- 1st Seminar: “How to Build a Project for Social Implementation of Basic University Research”
- Date & Time: X/X, 2025 (10:00~16:00)
- Speaker: Satoshi Suzuki, CEO of SSPO LLC
- Seminar Series:
- Business Development Seminar Series: Explanation of how to acquire GAP funds, business plan development, regulatory compliance, and overseas expansion strategy.
- Technical seminar by modality: Explain the commercialization process of biopharmaceuticals, nucleic acid drugs, regenerative medicine, and small molecule compounds.
Business Objectives
- Support for basic researchers and university-launched venture companies
We provide support to connect basic research born at universities and research institutes to commercialization.
By supporting GAP fund applications, building business plans, and formulating patent strategies, we will steadily lead research results to social implementation.
We share regulatory and go-to-market expertise to support the entire research and commercialization process.
2. Support for foreign companies entering the Japan market
We support regulatory applications, acquisition of manufacturing and sales licenses, and incorporation to comply with regulatory requirements unique to Japan.
We provide strategic advice tailored to cultural adaptation and market characteristics to ensure smooth business development.
3. Building an Industrial Ecosystem Using Networking
We provide a platform to promote collaboration between regular members and partner companies, and to promote knowledge sharing and joint research.
We will work to strengthen the ecosystem so that Japan innovations can demonstrate their value in the global market.
Main Activities
- Pharmaceutical industry support business
- Entrepreneurship Phase:
- We support customer selection, market research, and competitive analysis for technologies originating from universities that aim to commercialize research results.
- We also provide advice on intellectual property strategy and fundraising as needed.
- Founding Phase:
- We support technology transfer, non-clinical studies, and the development of manufacturing protocols.
- We specifically support the regulatory approval process, including GMP/GCP procedure preparation and PMDA consultation.
- Phase of operation:
- We support the establishment of a post-marketing system, manufacturing, sales, supply chain, and post-marketing surveillance to stabilize business operations.
- Entrepreneurship Phase:
- Awareness-raising seminars and training
- We will hold workshops to learn the knowledge necessary for GAP fund application and business construction.
- We provide state-of-the-art technology training specializing in biopharmaceuticals, nucleic acid drugs, regenerative medicine, and small molecules.
- Support for Foreign Companies
- We provide incorporation procedures, regulatory compliance, and GMP/GQP training necessary for entering the Japan market.
- We provide specific strategic proposals for success in the Japan market.
- Networking and promotion of joint projects
- We encourage collaboration with experts and partners inside and outside the association, and support joint research and business development that create new innovations.
Prospectus
As the decline in drug discovery capabilities becomes an issue for the people of Japan, there is an urgent need to build an ecosystem that supports university researchers and start-up companies. Through long-term support for solving problems, we will support the process from drug discovery to drug approval, and build the next generation of the pharmaceutical industry.
For Foreign CompaniesThe pharmaceutical market in Japan is said to be difficult to understand due to its complex regulations. We support the smooth market entry of foreign companies and act as a partner for their success in the Japan market.
Members of the Association and Sponsors
Regular Members:
- Satoru Suzuki Pharmaceutical Office LLC (SSPO): Provides extensive support for entrepreneurship, regulatory affairs, and quality assurance.
- Amenichi Corporation: CEO Keiji Asada, FDA/PMDA Expertise Delivered by Bilingual (Japanese & English) advisor.
- Pharma Initiative Support: CEO Yoshimoto Shiiki, an expert in business development, clinical trials, PMDA consultations, and TPP preparation.
Global Partners: Waiting you!!
Sponsors:
- Japan IR Co., Ltd.: Patient search specialty comapny. We co-host the seminar business.
Conditions for participation:
We welcome those who have the motivation and expertise to support the pharmaceutical industry as a full-time worker.
★ If you are one of these people, please contact us
University researchers who are thinking of commercializing it in the future (30-minute free consultation available)
Those who are preparing to apply for GAP funds, etc.
Wall-to-wall and second opinion of the application
Research support for universities and venture companies
Support for regulatory approvals and regulatory affairs
Lack of resources for venture companies
Support for the selection of CROs and CMOs
Overseas expansion support (U.S., Europe, Asia)
Holding Workshops and Seminars
You can also pay for services with a subscription.
Contact us: jpbsa@outlook.jp
by Satoru SUZUKI (SSPO:Satoru SUZUKI Pharma Office LLC)